Cardiocomm Solutions (EKGGF) 0.0809 $EKGGF CardioComm

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cardiocomm Solutions (EKGGF) 0.0809 $EKGGF

CardioComm Solutions Announces Release of GEMSTM Windows 7 Compatible, Remote Patient Monitoring Technology
ACCESSWIRE - Fri Mar 28, 9:01AM CDT
CardioComm Solutions to begin immediate rollout of GEMSTM for Windows 7 remote ECG analysis, data management software to extensive base of current US health care providers and customers.

Single Tranche Sale of CardioComm Solutions, Shares Completed
ACCESSWIRE - Wed Mar 26, 12:39PM CDT
Press release disseminated on behalf of Anatoly Langer

FDA Clears CardioComm Solutions' GUAVA II ECG Viewer with ECG Acquisition, Analysis, Interpretation, and Reporting Capabilities as a Class II Medical Device
ACCESSWIRE - Tue Feb 25, 7:47AM CST
GUAVA II offers regulatory credibility and efficiency to ECG reading services for physicians and hospitals

CardioComm Solutions Issues Stock Options
ACCESSWIRE - Thu Feb 20, 6:07PM CST
TORONTO, ONTARIO, February 20, 2014 - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that an aggregate of 567,460 incentive stock options have been granted to two directors of the Company and to a contractor of the Company. The 417,460 options issued to the directors are exercisable at $0.18 per share for five years from the date of grant, vest equally over 18 months at the end of each three month period from the date of grant and are subject to a four month hold period. The 150,000 options issued to the contractor are exercisable at $0.15 per share for five years from the date of grant, vest equally over 18 months at the end of each three month period from the date of grant and are subject to a four month hold period. The grant of options is subject to the provisions of the Company's Omnibus Share Compensation Plan, the policies of the TSX Venture Exchange and applicable securities laws.

CardioComm Solutions Completes Technology Pilot in the Long-Term Patient Care Market with the HeartCheck(tm) ECG Monitor and SMART Monitoring ECG Service Technologies
ACCESSWIRE - Fri Feb 07, 8:25AM CST
Arrhythmia Surveillance Utilized HeartCheck(TM) Device and SMART Monitoring ECG Service Technologies

CardioComm Solutions Closes Second Tranche of Equity Financing; Company Remains on Track to Complete $1 Million in Financing in Q1 2014
ACCESSWIRE - Fri Jan 31, 8:01AM CST
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") announced today it has closed the second tranche of its previously announced private placement equity financing. Under the financing, the Company issued 2,648,000 units at a price of $0.0675 per unit, for gross proceeds of $178,740. Each unit was comprised of one common share of the Company and one common share purchase warrant exercisable for two years for an additional share at a price of $0.10. For further information regarding the financing, please see the Company's press release that was issued on January 9, 2014. The gross proceeds from the financing will be used for general working capital of the Company. The shares and warrants issued by the Company are subject to a four month hold period which expires on May 31, 2014. The Company also confirmed that it will continue its current private placement equity financing offer.

CardioComm Solutions Executes Distribution and Co-Marketing Agreement to Promote HeartCheck(tm) PEN Sales and SMART Monitoring Services. SMART Monitoring Integration of Reka ECG...
ACCESSWIRE - Thu Jan 23, 4:08PM CST
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that it has completed a HeartCheck(TM) and SMART Monitoring distribution and co-marketing agreement ("Agreement") with Reka Health, Inc. (REKA), a US based company. REKA will promote sales of the HeartCheck(TM) PEN through their own, proprietary international distribution channels, including US-based accountable care organization ("ACO") patient portals.

CardioComm Solutions Issues Correction with Respect to Closing First Tranche of Financing
ACCESSWIRE - Wed Jan 22, 6:19PM CST
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today issued the following correction to its press release dated January 21, 2014 respecting the closing of the first tranche of its ongoing private placement equity financing: Please note that in the first tranche the Company issued 1,622,222 units at a price of $0.0675 per unit, for gross proceeds of $109,500.

CardioComm Solutions Secures $500,000 in GEMS(tm) 4 and GUAVA Software License Agreement. Licensing Deal Signals the Start of Sales of Windows 7 Compatible ECG Software Solutions
ACCESSWIRE - Wed Jan 22, 2:55PM CST
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that it has completed a software and source code licensing agreement ("SLA") for use of the Company's proprietary Global ECG Management Solution ("GEMS(TM)") and GUAVA ECG viewer by MD Primer Inc. ("MDP"). MDP is a clinical research and education organization enabling improvement in patient care through innovation. MDP is under the direction of Dr. Anatoly Langer, CardioComm Solutions' Chairman. As MDP is a related party of CardioComm Solutions, Dr. Langer abstained from voting on the SLA when it received board approval. The SLA is subject to approval by the TSX Venture Exchange.

CardioComm Solutions Closes First Tranche of Equity Financing. Company Plans to Complete $1 Million in Financing in Q1 2014
ACCESSWIRE - Tue Jan 21, 8:10PM CST
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") announced today it had closed the first tranche of its previously announced private placement equity financing. Under the financing, the Company issued $1,622,222 units at a price of $0.0675 per unit, for gross proceeds of $109,500. Each unit was comprised of one common share of the Company and one common share purchase warrant exercisable for two years for an additional share at a price of $0.10. For further information regarding the financing, please see the Company's press release that was issued on January 9, 2014. The gross proceeds from the financing will be used for general working capital of the Company. The shares and warrants issued by the Company are subject to a four month hold period which expires on May 21, 2014. The Company also confirmed that it will continue its current private placement equity financing offer.

CardioComm Solutions Re-Prices Previously Announced Equity Financing
ACCESSWIRE - Thu Jan 09, 5:47PM CST
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that it has re-priced its previously announced equity financing. The Company will now be conducting a private placement equity financing under which it intends to issue 15,000,000 units at a price of $0.0675 per unit for gross proceeds of $1,012,500. Each unit will be comprised of one common share of the Company and one common share purchase warrant exercisable for two years for an additional share at a price of $0.10. The securities to be issued under the financing will be subject to a four month hold period. The terms of the financing are subject to the approval of the TSX Venture Exchange.

Cardiocomm Solutions Appoints Industry Veteran As Vp Sales And Marketing To Build U.S. Based Patient Monitoring Software And Ecg Services Business
ACCESSWIRE - Wed Jan 08, 10:01AM CST
Former Executive of ScottCare, CardioNet and Lifewatch Corporation Set to Drive Sales of GEMS(TM) and Mobile Patient Monitoring Solutions into the U.S. Market

CardioComm Solutions Announces Equity Financing. Funding will be used as bridge financing to complete Q1 2014 objectives
ACCESSWIRE - Thu Dec 12, 12:53PM CST
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that it will be conducting a non-brokered private placement equity financing under which it intends to issue between 4,166,667 to 8,333,334 units at a price of $0.12 per unit for gross proceeds of $500,000 to $1,000,000. Each unit will be comprised of one (1) common share of the Company and one (1) common share purchase warrant exercisable for two (2) years for an additional share at a price of $0.18. The securities to be issued under the financing will be subject to a four (4) month hold period. The terms of the financing are subject to the approval of the TSX Venture Exchange.

CardioComm Solutions to Offer Free SMART Monitoring ECG Readings to HeartCheck(tm) Device Owners through GEMS Home in the United States. Free Cardiac Arrhythmia Surveillance Ava...
ACCESSWIRE - Tue Dec 10, 10:37AM CST
Toronto, Canada - CardioComm Solutions, Inc. (TSX-V:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, announced it shall be providing HeartCheckTM SMART Monitoring ECG services at no cost effective December 10, 2013 for its USA based customers who have been provided a HeartCheckTM device under a physician prescription.

Medical Electronics - Global Trends, Estimates and Forecasts, 2011-2018
M2 - Fri Dec 06, 4:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7plqm/medical) has announced the addition of the "Medical Electronics - Global Trends, Estimates and Forecasts, 2011-2018" report to their offering. The Medical Electronics Market Is Expected To Reach US$372.4 Billion By 2018. Globally, medical therapeutics and imaging systems together account for approximately 52.9% of the market and are expected to support the medical electronics industry going forward. Geographical analysis shows that the highest Compounded Annual Growth Rate (CAGR) of 17.2% is anticipated from Asia-Pacific region during the analysis period, 2011-2018. Among the application sectors, monitoring & surgical systems account for the largest share of the entire market, driving a CAGR of 13.4% during the analysis period 2011-2018. Imaging Systems see as the fastest growing application with a forecast CAGR of approximately 16.9% by 2018. Along with the fast growth and rapid advancement in technology related to healthcare industry, the medical electronics expectations have increased innovatively for large numbers of incurable disease. Publication Overview The report reviews the latest medical electronics market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for electronics sector investments. The study reveals profitable investment strategies for electronics companies, business executives, product marketing managers, new business investors and many more in preferred locations. The report primarily focuses on: - Emerging Market Trends - Advancements in the Technological Space - Market Demand of the Segments (By-Region) - Key Growth Areas and Market Size - Region-Wise Demand Factor - Key Competitors Edge - Investment Strategies More than 1346 leading market players have been identified in electronics industry. 51 key companies are profiled. Applications Covered - Monitoring & Surgical Systems - Medical Therapeutics - Imaging Systems - Diagnostics Examples of Companies Mentioned - 3M Healthcare - Abbott Vascular Devices - Baxter International - Becton, Dickinson & Co. - Blueradios - C. R. Bard - Cactus Semiconductor - Cardiocomm Solutions - Cardiomems - Digirad Corporation - Medtronic - Monebo Technologies - Novadaq Technologies - Perkinelmer - Siemens Medical Solutions - St. Jude Medical - Fukuda Denshi - Heartware - IBM - Indraprastha Apollo Hospital - Panasonic Electric Works - Microports Medical - Nihon Kohden Corporation - Covidien - Dr?ger Medical Ag & Co. - F.Hoffmann-La Roche - Ge Healthcare - Philips Medical Systems - Siemens Group - Smith & Nephew For more information visit http://www.researchandmarkets.com/research/b7plqm/medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

CardioComm Solutions' HeartCheck (tm) Technologies to be Used in Canadian Parkinson's Research Study. Second CIHR and Industry Sponsored Study to Use HeartCheck (tm) and SMART ...
ACCESSWIRE - Thu Dec 05, 3:23PM CST
Toronto, Canada - CardioComm Solutions, Inc. (TSX-V:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, announced it shall be providing HeartCheckTM based ECG screening technologies to researchers from the Research Institute of the McGill University Health Centre (RI MUHC) and the Montreal General Hospital (Quebec, Canada). This research study, which will be funded by the Canadian Institutes of Health Research (CIHR) and the Webster Foundation, will evaluate the potential relationship between caffeine intake and improvements in motor symptoms of persons with Parkinson's disease ("PD").

Cardiocomm Solutions Completes Mobile Cardiac Telemetry Software Release for Raytel Cardiac Services
ACCESSWIRE - Mon Nov 25, 2:17PM CST
Raytel Cardiac Services will be the first to launch into the American MCT monitoring market using the CardioComm Solutions Wireless Arrhythmia Services Software

CardioComm Solutions' GEMS Home & SMART Monitoring Technologies Expanded To Support Prescription, HeartCheckTM Handheld ECG Devices
ACCESSWIRE - Tue Nov 12, 6:32PM CST
Rapid physician ECG interpretation services now available to patients, allied health care workers and physician groups.

CardioComm Solutions Announces Shares for Services Transactions
ACCESSWIRE - Thu Oct 31, 7:00PM CDT
TORONTO, ONTARIO - October 31, 2013, CardioComm Solutions, Inc. ("CardioComm Solutions" or the "Company") (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 33,626 common shares of the Company in settlement of services provided, as previously described in the Company's press release dated October 11, 2013. The shares were issued to Mr. Simi Grosman, a member of the Company's board of directors, for services rendered to the Company in the months of July, August and September of 2013 pursuant to a services agreement dated January 11, 2013. The shares were issued at a 5% premium to the closing price of the Company's shares at the end of each month and represent a scheduled payment under the services agreement that will occur once per fiscal quarter. The total value of the shares issued is $4,500. The shares issued are subject to a four month hold period which will expire on February 22, 2014.

CardioComm Solutions Promotes HeartCheck (tm) PEN Consumer Awareness and Sales at the Toronto ZoomerShow
ACCESSWIRE - Thu Oct 24, 1:50PM CDT
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") will promote consumer awareness of the HeartCheckTM PEN handheld ECG device and offer free ECG readings to visitors this weekend (October 26th to 27th) during the ZoomerShow at the Direct Energy Centre in Toronto, Canada.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 362

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 39

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 481

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 298

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 419

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 583

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 407

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

Daily Insights on WisdomTree Fund Prices and Holdings Update

Updated Category News Views 284

WisdomTree Fund Prices Overview In today’s ever-evolving financial landscape, understanding fund prices is crucial for investors. WisdomTree Issuer plc offers a range of funds that are pivotal to the investment strategy of many. With the latest updates from the fund market, let's delve into the details of some notable WisdomTree funds available for investment. Key...

Continue Reading
Impact of Drug Tariffs on American Patients and Insurers

Updated Category News Views 290

Understanding the Proposed Drug Tariffs Introduced by the Administration Recent discussions have centered around proposed 100% tariffs on foreign pharmaceuticals, primarily advocated by the administration. Economists warn that these tariffs will place a heavy financial burden on American patients and insurers rather than the foreign drug manufacturers. Economic Insights...

Continue Reading
AvidXchange Q2 2025 Results: Growth Amid Strategic Changes

Updated Category News Views 445

AvidXchange Reports Strong Financial Growth in Q2 2025 AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leader in accounts payable (AP) automation software, has published its financial results for the second quarter ended June 30, 2025. The company showcases growth despite various strategic changes, particularly surrounding its pending acquisition. Financial Highlights for Q2...

Continue Reading
Talkiatry Ranks #6 in Digital Health Innovation for 2024

Updated Category News Views 552

Talkiatry Achieves Recognition in Digital Health Talkiatry has been honored as the sixth most innovative digital health startup for 2024. This accolade is a testament to the significant impact the organization is making in the field of behavioral health care. Significance of the CB Insights Ranking Chosen by CB Insights, Talkiatry's ranking reflects a combination of...

Continue Reading
Innovative Partnership Enhances SBA Loan Accessibility for Businesses

Updated Category News Views 267

BizBuySell and LoanBud Collaboration Enhances Financing for Businesses BizBuySell, the leading business-for-sale marketplace, has teamed up with LoanBud, a fintech innovator specializing in SBA financing. This collaboration significantly transforms the experience of buying or selling small businesses by increasing transparency and clarity in the financing process from the...

Continue Reading